| ATRS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ATRS shares outstanding history going back to 3/15/2010:
Also see: ATRS Market Cap History ATRS YTD Return |
ATRS Shares Outstanding History — Antares Pharma Share Count Over Time
As of 5/5/2022 Antares Pharma has 170.85 million ATRS shares outstanding. Investors often track the ATRS shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ATRS share count trends over time, with 51 historical shares outstanding datapoints presented, dating back to 3/15/2010.
| ATRS Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ATRS Historical Shares Outstanding: +6.19% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ATRS Stock Price Chart |
| About Antares Pharma Inc. |
| Antares Pharma is a pharmaceutical company focused primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. Co. develops, manufactures and commercializes, for itself or with partners, therapeutic products using its drug delivery systems. Co.'s U.S. Food and Drug Administration (FDA)-approved products include XYOSTED® (testosterone enanthate) injection; NOCDURNA® (desmopressin acetate); and Sumatriptan Injection USP. Co. is also the supplier of devices to Teva Pharmaceutical Industries, Ltd. for their Epinephrine Injection USP. We show 51 historical shares outstanding datapoints in our coverage of ATRS's shares outstanding history. Understanding the changing numbers of ATRS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ATRS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ATRS by allowing them to research ATRS shares outstanding history as well as any other stock in our coverage universe. |
| ATRS Current Stock Quote |
Quotes delayed 20 minutes  Free ATRS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ATRS Share Performance |
| Shares Outstanding Peers |
| Antares Pharma (ATRS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ATXI Shares Outstanding History ATXS Shares Outstanding History ATYR Shares Outstanding History AURA Shares Outstanding History AVAH Shares Outstanding History AVBP Shares Outstanding History AVCO Shares Outstanding History AVDR Shares Outstanding History AVEO Shares Outstanding History AVGR Shares Outstanding History More Healthcare companies » |
ATRS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
